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Abstract
An ex post facto design was used to examine the effects
exhibited at the site of

injection by elderly diabetics who reused

disposable insulin syringes and those who do not reuse syringes. The
hypothesis for the study was: There will be no significiant differences
in effects exhibited at the site of injection by elderly diabetics who
reuse disposable insulin syringes and those who do not reuse disposable
syringes.

Orem's Self Care Deficit Model was used to guide the

research.
The

sample

(£=42)

consisted

of

elderly

insulin

dependent

diabetics who had reused disposable insulin syringes (£=15), and those
who had never reused syringes (£=27).

All subjects were of the white

race with 24 (57.196) females and 18 (42.996) males. The mean age was
76 years. The number of years the subjects had diabetics ranged from
2 to 53 years (m_= 19.7 years).

The number of years each respondent

had taken insulin ranged from 1 to 53 years On = 10.2).
Data were collected using the Turner Effects of Syringe Reuse
Tool,

a

research

adapted

instrument

and

were

analyzed

using

two-tailed _t-test. Findings revealed no significant difference in effects
exhibited at
disposable

the site of injection by elderly diabetics who reused

insulin syringes and

Additional
demographic

findings

revealed

differences,

and

those who did not
certain
opinion

characteristic
and

differences between nonreusers and reusers.

iil

reuse syringes.

insulin

differences,

practice

habit

Conclusions drawn

from

this research

were consistent

with

previous research when applied to the elderly population. Implications
for care

of

the

elderly

insulin dependent diabetics utilizing

the

clinician, educator, and researcher roles was established.
Recommendations for further research using a larger sample size from
a more inclusive population and setting, and a longitudinal study was
made.

Also, conduction of research to solicit more information on

syringe reuse frequency, duration, and practice habits to establish if
there is a safe number of reuses for syringes was recommended.

The

need of a repetitive study to include a demographic and characteristic
profile of reusers and nonreusers was established.

Recommendations

for a repetitive study using the Turner Effects of Insulin Syringe
Reuse Tool to establish tool validity and reliability was given.

In

addition, the findings of this research needs to be presented to the
Center for Disease Control, Federal Food and Drug Administration and
the

American

Diabetes Association

universally.

iv

to effect a change in policy
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Chapter I
The Research Problem
Diabetes is a chronic, incurable disease that requires frequent,
often costly medical attention and teaching for self care. People with
diabetes must assume a major role in the management of their disease.
How people with diabetes manage their care in their home setting is a
scarcely researched area.

Intermittent observation by home health

personnel gives some enlightenment about the home management of
diabetes.

Observations and

reports given

by

people with insulin

dependent diabetes reveal reuse of disposable syringes. No mention of
clinical

observations of

infection at

the injection site

has been

discovered.
Sensitive health care providers must be aware of the economics
of

diabetes and

patients.

be

understanding of

the decisions made by

the

However, health care providers must also weigh the risks

versus the benefits of these decisions and provide counseling based on
scientific evidence to assist patients to make the best possible choices
regarding care.

If, in fact, no significant danger is incurred in the

reuse of disposable insulin syringes, it

would appear that current

practice and policy should be changed to correspond with research
findings. The geriatric nurse practitioner who understands the reasons
patients reuse disposable insulin syringes should not be forced to
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practice in violation of institutional policies and procedures. If, as it
appears, research findings are not definitive, institutional policies and
procedures could be modified to allow geriatric nurse practitioners to
at

least advise patients

regarding

the risks and benefits of

the

practice.
More research either leading to justification of the practice or
to strong evidence as to the deleterious effects of reuse of disposable
syringes should be done.

Therefore, the purpose of this study was to

examine the effects exhibited at

the site of injection by elderly

diabetics who reuse disposable insulin syringes.
Introduction to the Problem
There are a reported 6 million people with diabetes in the
United States, and this population will likely increase at least five to
six percent each calendar year (Center for Disease Control, 1982). The
exact number of insulin-dependent diabetics is uncertain. In Mississippi
there are approximately

75,000

known, and a similiar number of

unknown, people with diabetes. Of this 150,000, approximately 15% are
insulin-dependent (Nicolas, 1989). The total cost involved for all people
with diabetes in 1987 was reported at 20.4 billion dollars (National
Diabetes Information Clearinghouse, 1990).

The

total annual cost

specific to Mississippi for diabetes in 1987 was 20 million dollars.
Insulin dependent diabetics purchased 1.4 billion syringes at a cost of
278.9 million dollars in 1987.

These statistics are based on the

assumption that most insulin dependent diabetics use this syringe only
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once and discard (National Diabetes Information Clearinghouse, 1990).
The cost could be dramatically reduced if each syringe could be reused
with no loss of skin integrity for the diabetic. If all insulin dependent
diabetics were to use each syringe three times instead of once, the
yearly savings could total almost $78 million (Hodge, Krongaard, Sande,
& Kaiser, 1980).
The

care

and

teaching

involved

with diabetics pose

many

complex problems for health care personnel. The desire to provide the
best possible care, yet the most cost effective care for diabetics may
be a dilemma for personnel.

Presently, nurses instruct

insulin-dependent diabetics to use each disposable insulin syringe only
once and discard. This instruction is based on the belief that sterility
and patient skin integity is maintained with single use.
The Center for Disease Control (1977), the Federal Food and
Drug Administration and the Veterans Administration (1978) all have
issued the statement that disposable equipment is not to be reused.
Disposable plastic syringe needle units are packaged so as to preserve
sterility.

They have the advantage not only of sterility and ready

availability, but also, of consistent sharpness of needles, and of no
"dead space" in the syringe.

In 1983, the Federal Food and Drug

Administration reviewed the association's position on the issue of
reuse of disposable insulin syringes in response to disclosure of reuse
in a number of health care facilities.

The Federal Food and Drug

Administration concluded that a lack of data to support such a change
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in policy still existed (Center for Disease Control, 1982).

Thus no

change in their position on reuse occurred.
The practice of using each syringe only once for self-injection
were recently questioned from two different sources.

First, clinical

observations by home health care personnel revealed that people with
insulin-dependent diabetes in the community setting reuse syringes at
their own discretion. The second source of questioning was based on
clinical research that revealed no adverse effects were exhibited with
reuse of disposable insulin syringes (Crouch, Jones, Kleinbeck, Reece,
Bessman, 1979; Greenough, Cockcroft, Bloom, 1979; Hodge, Krongaard,
Sande, Kasier, 1980; Potect, Reinart, Ptak, 1987; Turner, 1989).
these studies attempts

were

made

to measure

the effects

In

upon

diabetics when they reused syringes as opposed to using each sterile
unit only once.

The researchers reported no significant differences

between subjects who reuse injection units and those who use a sterile
unit only once, and there was no evidence of inflammation at injection
sites for the duration of the study period. Greenough et al., (1979) and
Hodge et al., (1979) recommended that a larger group of subjects be
studied

over

a

longer

period

of

time.

Crouch

et

al.,

(1979)

recommended the development of a sturdier or replaceable needle to
prevent blunting. Although all of these studies used small samples, and
findings were inconclusive, some health care providers in various parts
of the country have altered their protocol for diabetic instructions
based on these findings (Alexander, Tattersall, 1988).
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Poteet, Reinert and Ptak (1987) studied frequency of multiple
use

of

disposable syringes among a sample of

diabetic

clients

in

an

ambulatory

diabetic

insulin dependent
clinic;

selected

characteristics of reusers and non reusers; and the outcome of cultures
on disposable needles and syringes used more than once.

The results

showed of 166 subjects surveyed that 74 reused their syringes.

Four

syringes were found to be contaminated with normal skin flora.
pathogenic organism was isolated.

No

No comparison studies have been

done and no research specific to effects exhibited by reusers versus
nonreuser's of

elderly diabetics in particular

could be found.

A

comparison study of effects exhibited by elderly diabetics who reuse
disposable

insulin syringes as compared

to nonreusers would help

provide data to support a change in protocol for health care providers.
Implication for Nursing Science
Because of the extensive cost involved in chronic illness, any
measure to conserve cost and continue to provide efficient care must
be implemented by health care personnel.

In an effort to provide the

most up-to-date information for client teaching, and based on the
report of reuse by clients already, continued research needs to be
done to investigate the reuse of disposable insulin syringes.

The

geriatric nurse clinician can use findings to educate insulin dependent
diabetic clients.

The results of this study may have the potential to

affect nursing management of the insulin dependent diabetic client and
alter existing protocol for the geriatric nurse clinican.
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Purpose of the Study
The genesis for this research lies with the need for definitive
data on effects exhibited at the site of injection by insulin dependent
elderly diabetics who reuse disposable insulin syringes. The purpose of
this study was to answer the following question: Do elderly diabetics
who reuse disposable insulin syringes exhibit effects at the site of
injection different than elderly diabetics who do not reuse syringes?
Theoretical Framework
Orem's (1985) theory of self care provided the conceptual basis
for this study.

Orem has six central concepts for the conceptual

framework which include self care, self care agency, therapeutic self
care demand, self care deficit, nursing agency and nursing system.
Orem defined self care as "action directed by individuals to themselves
or

their

environments

to

regulate

their

own

functioning

and

development in the interest of sustaining life, maintaining or restoring
integreted

functioning

conditions,

and

under

maintaining

well-being" (Orem, 1985).

stable
or

or

bringing

changing
about

a

environment
condition

of

One essential self-care action required to

promote regulation of one's functioning and well-being for an insulin
dependent diabetic is the administration of insulin.
The second concept of the self care agency is the person who
takes action to maintain health, makes judgements and decisions about
what to do and can perform measures to meet specific self care
requisites in time and over time. Further, therapeutic self care demand
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is the action required by the self care agency to maintain attention to
self as a self care agent and factors significant for self care, thereby
preventing a self care deficit.

Given that most diabetics learn and

provide their own insulin administration, the phenomena of self-care is
appropriate in this study.
Self care deficit is present when the self care agency is not
sufficient to meet the therapeutic self care demand.

A self care

deficit is an expression of inadequacy between the agency, an action
capability, and a set of action required for self care. Often the self
care deficit is in knowledge of self care and can be corrected through
supportive-educative

nursing

care.

People

with

diabetes

require

extensive teaching and need close follow-up care to evaluate the
application of and the need for further teaching.

As new research

provides data that effects the care of this group, the health care
providers are responsible to their clients to inform and educate them
appropriately.
Orem (1985) considered nursing to be a helping service, a
creative effort of one human being to help another human being. She
viewed the special concern of nursing to be the individual's need for
self-care action and

the provision and

management of

it on an

continuous basis in order to sustain life and health, and cope with
their effects. The ability to nurse is termed nursing agency, which is
developed and activated by individual nurses. Orem viewed the goal of

nursing agency to help people meet their own therapeutic self care
demands.
A nursing system constitutes the actions produced by nurses, as
they engage in diagnostic, prescriptive, and regulatory operations of
nursing practice.

Orem (1985) identified three types of regulatory

nursing systems: 1) wholly compensatory, 2) partly compensatory and 3)
supportive-educative.

The

supportive-educative

nursing system

is

selected when the patient can and should perform all self-care actions.
The supportive-educative nursing system is appropriate for the diabetic
patient who can and should perform all self-care actions.
The

geriatric

nurse

clinican

is challenged

by elders

with

diabetes to provide the helping service and actions they need to meet
their self-care demands

with a chronic illness such as diabetes.

Extensive education is needed initially and continues throughout the
course of

their illness.

The geriatric nurse clinician must be well

informed and constantly aware of changes that may effect the care
given to diabetics.

Helping clients and families to cope financially is

also needed in holistic care.

A diabetic faces certain fixed costs,

including physician visits, insulin, syringes, alcohol swabs, and other
supplies.

Cutting the cost in one of these area may improve patient

compliance and acceptance of this chronic disease state. The geriatric
nurse clinican must function as researcher to collect data and as
educator to inform the clients of results.
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Much education is required to prepare the self-care agency to
maintain well-being.

The nursing agency must teach a diabetic all

aspects of self-care to maintain their well-being, therefore the need
for

up-to-date

information

pertaining

to

the

treatment

and

management of diabetes is of utmost importance.
Assumptions
This study was based on the following assumptions:
1.

Inflammation

at

the

injection site

is a

valid indicator of

bacterial/fungal cutaneous and subcutaneous infection.
2.

Elders reuse insulin syringes.

Problem Statement
The

problem statement

for

this research proposal was:

Do

elderly diabetics who reuse disposable insulin syringes exhibit effects
at the site of injection different than elderly diabetics who do not
reuse syringes?
Hypothesis
The hypothesis for this research proposal was: There will be no
significant difference in effects exhibited at the site of injection by
elderly diabetics who reuse disposable insulin syringes and those who
do not reuse disposable syringes.
Definition of Terms
The following operational definitions are utilized in this study:
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Effects—exhibited

are

characterized

by

redness,

lumpiness,

swelling, tenderness or heat at the injection site, either reported or
observed using the Turner Effects of Insulin Syringe Reuse Tool.
Elderly diabetic in this study was defined as 55 years and older
who is an insulin dependent diabetic with no existing skin integrity
problems either reported or observed using the Turner Effects of
Insulin Syringe Reuse Tool.
Reuse was defined as more than one time use of disposable
insulin syringes as reported on the Turner Effects of Insulin Syringe
Reuse Tool.
Do not reuse was to use disposable insulin syringes only one time
as reported on the Turner Effects of Insulin Syringe Reuse Tool.

Chapter II
Review of the Literature
The concept of disposable insulin syringe reuse has been well
established in the literature, however, studies specific to the geriatric
insulin dependent diabetic have not been reported.

No studies were

found to compare the effects exhibited by insulin dependent diabetics
who reuse syringes and those who do not.

Therefore, the need for

further research into the phenomena of syringe reuse in regard to the
elderly diabetic was substantiated.

A review of literature revealed

five studies that provided background and structure for the study.
The first clinical trial of reuse of syringes was conducted in
England (Greenough et al., 1979).

A sample of 30 outpatients, with a

mean age of 44, participated in an investigation in which each patient
used the same disposable syringe for up to two months, changing the
needle after three or four days if it became blunt (p. 1468).
Subjects participating in this study were not given directions for
injection or care for their syringe units in any way different from
their

usual practices.

Subjects were questioned about the use of

alcohol swabs and any measures taken to assure the sterility of their
disposable units.

Most of the patients in the study swabbed both the

top of the insulin bottle and the skin with alcohol before injection, but
5% swabbed neither.

Most of the patients in the study boiled their
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syringe needle from time to time.

The researchers concluded that

"despite all these precautions or lack of precautions, local infections
at the site of injection are rare in diabetics, even in those with whom
cleanliness is not a feature" (p. 1467).
Throughout the clinical trial by Greenbough et al., (1979) no
tenderness

or

redness

at

the

site

of

inflammation were detected on inspection.

injection

and

no

local

The study was conducted

over eight weeks. Sixty used syringes were collected for culture, and
59 of these yielded no pathogens. One syringe, which had been in use
for a month, yielded Staphylococcus albus, which was present in the
cultures from hands and abdomen in this patient.

The researchers

recommended reuse of disposable syringes for a fortnight or 14 days,
since such

usage appeared safe and could result in "considerable

national savings" (p. 1468).

In fact, "throwing away a syringe and

needle after a single injection seems unnecessarily wasteful" (p. 1468).
If all insulin dependent diabetics were to use each syringe three times
instead of once, the yearly savings would be almost $7.8 million.

A

recommendation for additional research using a larger sample over a
longer period was given.
In another clinical

trial conducted in the United States, 18

inpatients were selected randomly by chart number and were asked to
reuse disposable syringe and needle units for self injection until the
needle became to dull to use (Crouch et al., 1979).
variables in this study were:

The dependent

(a) incidence of infection; (b) clarity of
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syringe readings; and (c) sharpness of the needle.

In the published

account of this study, there were no specifications as to the total
length of the clinical trial, but it was reported that the plastic syringe
units were stored in 70% alcohol between uses.

No mention was made

relative to use of aspectic technique by the individual subjects.
Crouch et al., (1979) reported the following findings.

First,

there was no incidence of infection at injection sites on any of the
subjects.

Second, the calibrations on the syringes remained readable

throughout the trial.

And third, nine out of 18 subjects were able to

reuse the syringe-needle unit for four days, and 14 out of 18 subjects
were able to reuse the syringe-needle unit for three days before the
needle became too blunt to use with comfort.

These researchers did

not directly endorse reuse of plastic syringe and needle units, but they
did say "since needle dullness was the precipitating cause for requiring
a new disposable syringe-needle unit, the manufacturers should be
encouraged to develop a sturdier or replaceable needle".
In

a

third

clinical

trial,

14

insulin-dependent

diabetic

outpatients, were asked to use their insulin syringe units for three
successive injections to determine the effectiveness and safety of this
practice (Hodge et al., 1980). The mean duration of time each patient
participated in

the study was 20.4 weeks, and a total of

injections were administered throughout the trial.

2,000

Before the study

was actually begun, several multidose insulin vials were injected with
Staphlococcus aureus to determine the viability of the organism in this
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solution. Forty-eight hours after innoculation of vials, the researchers
found no growth of
finding

to the

preservatives.

the implanted organism.

various substances that
It

would seem

that

They attributed this

were added to insulin as

these preservatives were also

bacteriocidal.
The 14 subjects ranged in age from 36 to 70 years. The other
selection criterion was that no subject could have any evidence of skin
disease prior to the study.
with

All subjects were asked to rub the skin

an alcohol swab two or

Although
additional

in

the

published

measures

taken

three times in a circular manner.

results
to

there

teach or

was
reteach

no

description

of

patients aspectic

self-administration, the subjects were assessed at intervals by a nurse
practitioner. No signs of infection at the injection sites were observed.
These researchers concluded that "multiple use of disposable insulin
syringes appears to be safe and cost beneficial".

Reuse of syringe

units could be very cost beneficial to the insulin dependent diabetic
person, Hodge et al., (1980) estimated such savings to be at least
$50.00 per year per client, or about 78 million dollars a year to the
overall health care delivery system.
As a result of the finding by Greenough et al., Hodge et al., and
Crouch et al., the British Diabetic Association issued a statement
advising that plastic syringes may be reused up to five times. No such
changes occurred in the United States.
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In 1983, Turner conducted a study to provide descriptive data
about single versus multiple use of

syringe and needle units for

self-injection

diabetic

by

insulin-dependent

persons.

She

also

investigated relationships between inflammation at injection sites and
reuse of syringe and needle units to establish a rate of occurance of
inflammation at injection sites of insulin dependent diabetes mellitus
(IDDM) persons.
A convenience sample of 302 subjects, ages 10 to 86 years with
the mean age of 54.9, were selected from two outpatient facilities.
The Windsor Performance Index for self-administration of insulin was
administered and evaluated by the researcher.

Also, the sample was

visually assessed and verbally interviewed about signs and symptoms of
present or past inflammation at injection sites.
was completed in interview format.

General information

Lastly, the sample completed a

self-administered multidimensional Health Locus of Control Scale to
measure

belief

in

ability

to

control

one's

health.

A

set

of

investigator generated questions was used to solicit subjects' attitudes
and practices toward reuse of syringe units.
A

total

of

9.9%

of

subjects

inflammation at injection sites.

reported

a

past

to

39.6%).

A

of

A chi-square test revealed differences

in the reported rate of reuse of syringe units by race.
compared

history

_t-test

revealed

differences

(51.2% as
in

age,

(t(302)=-2.82) and years of insulin-dependency (t(302)=-4.61) between
the reuse group and the one-time only use group.

The level of
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statistical significance was .05.

Older, nonwhite diabetics who were

insulin—dependent for 10 years or more were apt to reuse syringe units.
Neither the score obtained on the performance index nor the practice
of reusing disposable units was significantly related to reports of
inflammation,

although

findings

closely

approached

significance.

Reexamination of previous research and further investigation into the
relationship between

reuse

of

syringe

units and

inflammation at

injection sites was recommended.
More recently a study of 166 insulin dependent diabetics, age 22
to 77, who attend an ambulatory clinic and were responsible for their
own insulin injection was done to determine frequency of reuse of
disposable insulin syringes (Poteet, Reinart, Ptak, 1987). Syringes of
reusers were cultured for bacterial growth. The frequency of multiple
usage

of

disposable insulin syringes among 166 insulin dependent

diabetes was 44.6% or 74 subjects.

Of

the 74 who reused their

syringes, 67 reused them 2 to 4 times and 7 reused them 5 to 20 times.
More subjects in the age range of 75 to 77 tended to reuse syringes.
Syringes from randomly selected 44 insulin dependent diabetics who
required more than one dose of insulin per day were cultured for
bacterial growth and resulted in four with normal skin flora growth
and none with pathogenic growth.

Recommendations for more research

to lead to justification of the practice of reuse or to strong evidence
as to deleterious effects of reuse of disposable syringes was given.
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Clinical
Greenough

et

research
al.,

has been conducted (Crouch et al., 1979;

1979;

&

Hodge

et

al.,

1980)

in

which

the

recommendations for one time use of disposable insulin syringes for
self-injection were questioned. Essentially, these studies were designed
to measure the effects on diabetics when they reused syringes, as
opposed to using each sterile unit only once.

The three groups of

researchers reported no statistically significant difference between the
outcome of single versus multiple use.
A review of literature revealed previous research conducted on
the reuse of disposable insulin syringes. Small sample sizes were used
and short durations of study.

No research was found to be specific to

the elderly diabetic client, although elderly diabetics were found to
reuse syringes more frequently (Turner, 1983).

All studies concluded

with recommendations for further research to provide data to support
the reuse of disposable insulin syringes. The need for research specific
to the elder diabetic also was substantiated.

Therefore, this current

study focused on the effects exhibited by elderly insulin dependent
diabetics who reuse disposable insulin syringes and those who do not
reuse syringes.

Chapter III
The Research Design
The purpose of this ex post facto study was to examine the
effects exhibited at the site of injection by elderly diabetics who
reuse disposable insulin syringes.

In an ex post facto design study

variations in phenomena are studied after the variations have occurred
rather than at the time of occurrance.

Ex post facto design is both

comparative and retrospective and involves no manipulation of any
variables (Wilson, 1989).

Because no manipulation of a variable was

done, only the examination of present and past phenomena, as reported
by elderly diabetics, this design was appropriate for this study.
Variables
The dependent variable of interest was the effects exhibited at
the site of injection by elderly diabetics who reused disposable insulin
syringes, as determined by the research adapted, Turner Effects of
Insulin Syringe Reuse Tool.

The independent variable was use of

disposable insulin syringes by elderly insulin dependent diabetics.

The

control variables included age, skin integrity, and insulin dependency.
An intervening variable may have been the honesty with which the
subjects responded to the questionnaire and their ability to determine
skin conditions.
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Internal and External Validity of Design
The only identified threat to internal validity may have been a
selection bias, as the sample included solicited elder subjects from a
community setting.

External

validity may have been affected by

experimenter bias since questionnaires were answered in the presence
of the researcher. However, the researcher attempted to exert control
by remaining out of the sight of subjects unless responding to their
questions.
Limitations
One limitation of

this study was the fact that the sample

consisted of elderly diabetics in Mississippi, preventing generalization
to all diabetics. Another limitation was the small sample size.
Setting, Population and Sample
The

setting

for

northeast Mississippi.

this study

included two rural counties

in

In 1980, Mississippi's population was 2,613,000

(United States Department of Commerce, 1982).
population lived in rural areas (53%).

At least half of the

Mississippi has a predominately

agricultural ecomony with a per capita income well below the national
average (Goetz, 1987).

In 1980, Mississippi had a reported 67,080

people with diabetes, of which 43,924 were 55 years of age and older
(National Diabetes Information Clearinghouse, 1990).

An undetermined

number of these diabetics reside in the two counties selected for this
study.
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The population for this study included all insulin dependent
diabetics who were 55 years of age or older and lived in these two
counties. The sample of convenience included are subjects who met the
criteria for this study and consented to participate. Question 5 on the
Turner Effects of Insulin Syringe Reuse Tool was a yes-no response for
current reuse of syringes and was used to divide the sample into two
groups for analysis. Group one included 27 subjects who do not reuse
their disposable insulin syringes, while Group two included 15 subjects
who did reuse their disposable insulin syringes.
Instrumentation
Data were collected using the Turner Effects of Insulin Syringe
Reuse Tool (See Appendix A), a researcher-adapted instrument.

The

self-administered tool contained 25 questions. The first three questions
contained criteria for study participation.

Six general information

questions were included which solicited demographic data including
race, sex, age, marital status and estimated yearly income.

Seven

questions pertaining to the individual history of diabetes and insulin
use

were included.

The

remaining 10 questions contained insulin

syringe use habits and opinion on reuse of syringes.
The

Turner

Effects of

Insulin Syringe

Reuse Tool

had no

established reliability or validity since it was researcher adapted from
the original tool.

However, the original tool, The Practice of Single

Versus Multiple Use of Syringe Units as Reported by Insulin Dependent
Diabetics, was tested (reliability coefficient on the performance index
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was .710) and found highly statistically reliable (Turner, 1983).
researcher

adapted

the

original

tool

by

omission

of

a

The

diabetic

performance indice and rewording of questions for scoring purposes.
The adapted

tool was assumed

to have face validity within the

confines of this study.
In a effort to minimize instrumentation errors, a pilot study was
conducted using a convenience sample of five elderly insulin dependent
diabetics who volunteered to review the Turner Effects of Insulin
Syringe Reuse Tool for clarity and content.

Results of the pilot study

indicated that content was relevant and questions were understood
clearly, therefore no adjustment to the tool was made.
Data Collection/Procedure
Following approval by the Committee on Use of Human Subjects
in Experimentation at Mississippi University for Women (see Appendix
B), the researcher contacted a home health agency, which serves the
two

Northeastern

counties

in

Mississippi,

for

consent

to solicit

participation in the study from the diabetic caseload that met the
criteria (see Appendix C and D). In addition, the researcher conducted
free blood sugar testing for elderly insulin dependent diabetics in the
two counties and asked

for voluntary participation in

the study.

Subjects were provided privacy and allowed time to complete the
questionnaire. The researcher was available to visualize skin integrity
as indicated on the tool, but remained out of the sight of subjects
unless

needed.

Tools

were collected by the researcher for data
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analysis.

Data were collected during the months of May and June,

1990.
Data Analysis
Data

were

significance.
difference

analyzed

A _t-test

between

the

is

using
a

means

the _t-test

parametive
of

two

at

test

the .05 level of
that

groups of

examines
values and

particularly useful with small sample sizes (Wilson, 1989).

the
is

The t-test

was appropriate to data between the effects exhibited at the site of
injection by the elderly diabetics who reuse insulin syringes and those
who do not reuse syringes.

Chapter IV
Results of Data Analysis
The purpose of this study was to examine the effects exhibited
at the site of injection by elderly diabetics who reused disposable
insulin syringes and elderly diabetics who did not reuse disposable
syringes.
study.

The research design was ex post facto, a nonexperimental

The hypotheses were analyzed using t-test while demographic

responses

were

analyzed

frequencies and means.

using

descriptive

statistics

including

In this chapter the sample and the results of

the data analysis are presented. Additional findings also are included.
The Sample
The

sample

(ri=42)

consisted

of

elderly

insulin

dependent

diabetics who had reused disposable insulin syringes (£=15), and those
who had never reused syringes (£=27).

All subjects were of the white

race with 24 (57.1%) females and 18 (42.9%) males.

The ages of the

subjects ranged from 64 to 92 years, with a mean of 76 years. Marital
status was reported as 2 (4.8%) single, 23 (54.8%) married, 16 (38.1%)
widowed, and 3 (2.4%) divorced.

Of the subjects 21 (50%) lived with

their spouses; 2 (4.8%) live with their children; 15 (35.7%) lived alone,
and 4 (9.5%) lived with some other relative. Total family income for
last year was reported as less than $5,000 (£—27; 64.3%) and $5,000 to
$10,000 (n=15; 35.7%).

Data collected from the sample revealed the

number of years the subjects had diabetes ranged from 2 to 53 years
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(— = 19-69 years).

The number of years each respondent had taken

insulin ranged from 1 to 53 years (m = 10.238). Of the sample 35 (83%)
received education regarding insulin injection at the time of diagnosis,
while 7 (16.7%) did not. The sample reported that 30 (71.4%) give their
own injections, while 12 (28.6%) receive their shot from another person
13 (31%) by family, 1 (2.4%) by friend.

Of the sample 37 (88.1%)

reported that nurses taught them to give their shots; 2 (4.8%) taught
themselves; 2 (4.8%) did not know who taught them. The majority 30
(71.4%) of the sample reported no additional teaching regarding insulin
injections since the initial education. Insulin usage was reported as the
number of units per day being from 10 to 130 units (m=47, median=42).
Respondents that received 2 injections per day were 22 (52.4%) and 20
(47.6%) received only one injection per day.

In addition, 23 (66.7%)

used NPH insulin and 14 (33.3%) used NPH and regular insulin.

The

variable redness was reported in 2 (7.4%) nonreusers and 0 (0%) in
reusers.

Lumpiness was reported for 2 (7%) nonreusers, and for 1

(6.7%) reusers.
and

Nonreusers respondents reported tenderness in 2 (7.4%)

2 (13.3%) reusers.

swelling.

Heat

No respondents

reported

the symptom of

was reported by 2 (13.3%) reusers. No nonreusers

reported heat.
Data Analysis
The hypothesis was there is no significant difference in effects
exhibited at the site of injection by elderly insulin dependent diabetics
who reuse disposable insulin syringes and those who do not reuse was
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accepted by the researcher.

Data were analyzed using the _t-test at

the .05 level of significance.

Respondents were asked to self-report

five adverse

may

reactions they

have had

at

the site of

their

injections by simple yes-no responses. Data analysis of the 5 variables
revealed the following values:

redness _t(42)=1.07, p = 2.91; lumpiness

_t(42) = .09, p = .73; tenderness _t(42) =.61, p = .542; heat t(42) = -1.99,
p = .054; swelling _t(42) =.00, p=1.00 (see Table 1). Since there was not
a signficiant statistical difference in effects exhibited at the injection
site, the researcher failed to reject the hypothesis.

These data are

presented in Table 1.
Table 1
Comparison of Variables in Nonreusers and Reusers Using the t-Test
n

Variable
redness

lumpiness

tenderness

swelling

SD

Non 1
o
Re

27

.74

.27

15

.00

.00

Non

27

.74

.27

Re

15

.06

.26

Non

27

.07

.27

.13

.35

Re

15

Non

27

O
O

heat

M

.00

Re

15

.13

.35

Non

27

.00

.00

Re

15

.00

.00

^"Non = Nonreusers
2 Re = Reusers

_t

1.07

.09

.61

-1.99

.00
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Additional Findings
The researcher also was interested in the insulin practice habits
of reusers and nonreusers, Questions 1, 3, 4, 5, 6 of the Turner
Effects of Insulin Syringe Reuse Tool addressed this issue and were
first analyzed using descriptive statistics, then the two groups were
compared using a 2 tailed jt-test. The results are reported by question,
including 1, 3, 4, 5, and 6.
Question 1 was "it is ok to reuse disposable insulin syringes."
The following findings emerged: 16 (59.3%) of the nonreusers agreed
and 9 (33.3%) disagreed while only 2 (7.4%) of the respondents strongly
disagreed that it was ok to reuse syringes.
agreed

it

was ok

to

reuse syringes.

Of the reusers 15 (100%)

Group comparison

revealed

significant difference at .05 level (_t(40) = -2.89, p=.006). (see Table 2).
Question 3 yielded numerical value for the number of times a
single needle

and

syringe unit

had

been

nonreusers had reused a needle 2 times.
reused the syringes 2 times.

reused.

Two (7.4%) of

Eight (53.3%) respondents

Reusers (n=15) had a mean of 3.8 and a

median of 2.00. Two-tailed _t-test analysis revealed _t(40) = -8.71, p=.00
which was signficiant difference at the .05 level.
Question 4 was the frequency of reuse of syringes in a month's
time.

One (3.7%) of the nonreusers reused a syringe less than once a

month, while 2 (7.4%) reused 2 or 3 times a month.

Two (13.3%)

reusers had a less than once a month frequency and 2 (13.3%) had
about once a month frequency, while 11 (73.3%) of reusers reported a

27

frequency of once a week or more. Two-tailed jt-test analysis revealed
t(40) = -9.99, p = .000).
Question 5 was for current syringe use practice and was used to
divide the sample into the two groups for analysis.

Yes-no responses

for reuse were used and data were consistent with _t-test (n=27, n=15.)
Two-tailed _t-test analysis revealed _t(40) = 6.91, p=.00, significance
difference at the .05 level.
Question 6 was "who told you it was ok to reuse syringes."
Twenty (74.1%) of nonreusers had never been told, while 7 (25.9%)
were told it was ok by some source other than nurse or doctor.

Two

(13.3%) of reusers reported nurses told them and 4 (26.7%) had never
been told, while 9 (60.0%) were told by some other source. Two-tailed
_t-test analysis revealed _t(40) = -4.07, p=.000. These data are presented
in Table 2.
The

researcher

was

also

interested

in

the

demographic

characteristics of reusers versus nonreusers. Data were analyzed using
descriptive statistics, then correlated using chi-square. Marital status
characteristics revealed 2 (7.4%) nonreusers were single, 0% reusers;
11 (40.7%) married nonreusers, 12 (80.0%) reusers; 14 (51.9%) widowed
reusers, 1 (13.3%) reusers; 0% divorced nonreusers, 1 (6.7%) reusers.
Chi-square analysis revealed significant difference at .05 level (x 2 (3) =
9.38 p

=

.025).

Living arrangements revealed nonreusers living with

spouses 9 (33.3%), 12 (80%) reusers; 2 (7.4%) living with a child for
nonreusers, 0% reusers; 14 (51.9%) living alone nonreusers, 1 (6.7%)
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Table 2
Comparison of Insulin Practice Habits of Nonreusers and Reusers By
Question Response on the Turner Effects of Insulin Syringe Reuse Tool
Using t-Tests

Ql c

Q3

Q4

Q5

Q6

M

SD

N=27

1.52

.64

R=15 C

2.00

.00

N=27

.15

.54

R=15

3.80

2.18

N=27

.26

.81

R=15

3.33

1.18

N=27

.07

.27

N=15

.80

.41

N=27

.19

.40

N=15

.73

.46

-2.89*

-8.71**

-9.99**

-6.91**

-4.07**

*£=.006, **£=.000

Note:
a) Q= Questions on the Turner Effects of Insulin Syringe Reuse Tool;
b) N=nonreusers
c) R=reusers

29

reusers; 2 (7.4%) living with others, nonreusers, 2 (13.3%) reusers.
Significant difference was determined by chi-square analysis (x 2 (3) =
11.18, p - 0.108). "Who told subjects it was ok to reuse syringes" or if
they had never been told revealed nonreusers told by nurse 0%, 2
(13.3%) reusers; 7 (25.9%) nonreusers told by other, 9 (60.0%) reusers;
20 (74.1%)

nonreusers

never

told

it

was ok,

4 (26.7%)

reusers.

Significant difference was found on chi-square analysis (x 2 (2)=10.33, p
=.006).

Chapter V
The Outcome
The

purpose

of

this research

was

to

examine the effects

exhibited at the site of injection by elderly insulin dependent diabetics
who reused disposable insulin syringes and elderly diabetics who do not
reuse disposable insulin syringes.
answer the question:

An ex post facto design was used to

Do elderly insulin dependent diabetics who reuse

disposable insulin syringes exhibit effects at

the site of injection

different than elderly diabetics who do not reuse syringes?
The sample consisted of 42 elderly insulin dependent diabetics.
Twenty-seven (64.3%) were nonreusers and 15 (35.7%) were reusers.
Data were collected using the Turner Effects of Insulin Syringe Reuse
Tool, a research-adapted instrument.

Five variables were used to

evaluate skin integrity.
Statistical
two-tailed Jt-test.

analysis

included

descriptive

methods

and

a

One hypothesis guided this study: There will be no

significant difference in effects exhibited by elderly diabetics who
reuse disposable insulin syringes and those who do not reuse disposable
syringes. Since the hypothesis was not significant at the .05 level, the
researcher failed to reject the hypothesis.
Additional findings revealed certain characteristic differences
between nonusers and reusers; demographic differences; and opinion
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and insulin syringe practice habits differences between nonreusers and
reusers.
syringes.

These findings seem significant

to the decision to reuse

Discussion, conclusions, and implications of

findings are

presented in this chapter.
Discussion and Conclusions
Previous studies (Greenough et al., 1979; Crouch et al., 1979;
Hodge et al., 1980; Turner, 1983; and Poteet et al., 1987) revealed no
significant difference between the outcome of single versus multiple
use of disposable insulin syringes.

The findings of this current study

support these findings.
Previous studies did not use age as a control variable. Samples
were primarily younger and the researcher questioned their findings
when applied to the elder population. The current study controlled age
and confined the sample to 55 years of age and older (m_ =76.4 years
of age) and supported previous findings. Since no evidence of infection
or inflammation was observed or reported, age was not believed to be
a factor in effects exhibited by reuse of disposable insulin syringes.
Previous studies conducted also were confined to samples from
health care facilities (inpatient and outpatient clinics), which may
have been a more health conscious, interested sample.

The current

study was conducted with a sample of community based elders. The
results were consistent with previous findings.

Thus, setting was not

believed to effect reuse of disposable insulin syringes.

In addition,

previous and current research have been of short duration with small
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sample size. Therefore, the researcher would recommend a longitudinal
study be conducted using a larger sample size from a more inclusive
population and setting.
This current

research included opinion and syringe practice

habits of diabetics and found that there were significant differences
between nonreusers and reusers. The majority of reusers had diabetes
longer

and

had

been

on

injections longer

than

nonreusers.

The

researcher concluded that because of the span of chronic illness and
accumulated expenses and the longevity of syringe use and cost may
have been a significant factor for reuse.

The majority of 20 (74.1%)

nonreusers had never been told it was ok to reuse insulin syringes be
any source.

Nine (60%) of reusers had been told it was ok to reuse

syringes by some source other than a nurse or doctor. Thus, the lack
of

knowledge

and

professional

input

regarding

reuse

may

have

influenced the action of the sample.
Since no previous research reported opinions and practice habits
of diabetics, the findings of this study can neither be supported or
refuted.
sample

Previous and current research has failed to ask how long the
has

reused

syringes

and

practice

habits,

therefore,

the

researcher would recommend a study be conducted to solicit more
information on syringe reuse frequency, duration, and practice habits
to establish if there is a safe number of times to reuse syringes and
any practice habits that may prevent adverse effects.
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Certain demographic differences were
research.

noted

in the current

The characteristics of the sample found most reusers to be

married (80%) and to have income of less than $5,000 per year (53.3%).
They also were found to have had diabetes longer (m=25.1 years) and
taken insulin longer (m=13.3 years) than

nonreusers.

Perhaps this

rationale of longer duration of expenses and dependent needs also
explains their cost conservation.

Therefore, a repetitive study to

include a demographic and characteristic profile of nonreusers and
reusers is recommended.
People

with

diabetes

must

assume

a

major

role

in

the

management of their disease. Orem's Self Care Deficit Model provides
the supportive educative nursing needs for people to maintain self
care. Since 74.1% of nonreusers had never been told it was ok to reuse
syringes

implementation of

education.
They

must

Orem's Model is indicated in diabetic

Information given to diabetics is vital for their disease.
have accurate

and

up-to-date

information.

It

is the

responsibility of health care providers to be aware of research and
changing policies and relay this information to their clients.
with diabetes deserve to know of
signficiant

difference

between

People

research findings indicating no

single

versus

multiple

reuse

of

disposable insulin syringes and make the decision appropriate for their
needs.
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Implications for Nursing
Findings and conclusions of this study have implications for the
clinical

practice,

clinician.

education,

and

researcher

roles

of

the

nurse

Each role will be utilized in management of the elderly

insulin dependent diabetic .
The clinical practice area will include treatment, management,
and continuing education for the elderly insulin dependent diabetic.
The clinician must understand why clients make decisions and base
their

treatment

conservation

and

certainly

education
must

according

to

their

be considered

in

the

needs.

Cost

management

of

clients with chronic illness who face many medical expenses and costs
of treatment.

Nurses in the expanded role are in a unique position to

establish their own protocol.

Using current research results to guide

their protocol changes and remaining current with ongoing research
will facilitate quality patient care and impact upon the practice area.
If reuse of

disposable insulin syringes is safe and certainly cost

effective, many clients can benefit from this knowledge provided by a
health

professional

with guidelines for

use and education of side

effects to report to prevent untoward reactions if any.
In addition, by virtue of their collaborative roles, these nurse
practitioners are able to provide continuing education for other health
care providers and impact upon their practice. Therefore, nurses in the
expanded role need to be constantly aware of

research and new
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clinical evidence that will influence her practice and be important for
client education.
Education

is

vital

dependent diabetics.

in

the

management

of

elderly

insulin

It will be a continuing process for their care.

This education is essential and must be based upon current practice
and research findings.

If syringe reuse is found to be safe and

effective, diabetics deserve to be informed as early as possible and
educated by a health professional to prevent misinformation and side
effects.

In the expanded role as educator, the nurse clinican is also

responsible
providers

to
to

the

community,

educate

them

students,

using

the

and

most

other
currently

health

care

acceptable

practices.

Education is a vital role of the clinician. Using Orem's

Model

Supportive-Educative

of

nursing

will

provide a conceptual

framework for the practice.
Research is a vital process for the continuation of

quality

nursing care. In an effort to provide efficient, cost-effective care and
the most up-to-date information for our clients, research is imperative.
As indicated

by

this study,

research

will

be

important

management of elderly insulin dependent diabetics.
previous research

for

the

This study and

need to be presented to the American Diabetic

Assocation, Federal Food and Drug Administration and Center for
Disease Control in support of a universal change in protocol.
clinician

may

choose to

be an active participant

The

in research or
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consumer of ongoing research. Both areas will impact on the practice
and education roles of the nurse practitioner.
Recommendations
1.

Implementation of research using a larger sample size from

a more inclusive population and setting and a longitudinal study is
recommended.
2.

Conduction of

research

to solicit

more information on

syringe reuse frequency, duration, and practice habits.
3.

Implementation

of

a

repetitive

study

to

include

a

demographic and characteristic profile of reusers and nonreusers.
4.

Implementation

of

a

repetitive study

using

the Turner

Effects of Insulin Syringe Reuse Tool to establish tool validity and
reliability.
5.
Drug

Presentations of

Administration,

research findings to Federal Food and

Center

for

Disease

Control,

and

American

Diabetes Association in support of a universal change in protocol.
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T u r n e r ' s E f f e c t s of Insulin Syringe Reuse Tool
D ata Collection Tool
I am a s t u d e n t a t t h e Mississippi University for Women who is interested
in how diabetics g i v e their insulin a t home. I would like for you t o answer a
few questions while you a r e waiting h e r e . Any information you give me will be
treated in a c o n f i d e n t i a l manner. P l e a s e do not w r i t e you name on this
questionnaire.
CIRCLE THE ANSWER
Do you t a k e insulin?
1.

YES

NO

Have you e v e r e x p e r i e n c e d a n y of t h e following symptoms a t t h e injection
site?
redness

YES

NO

lumpiness

YES

NO

swelling

YES

NO

tenderness

YES

NO

heat

YES

NO

*2.

Do you h a v e a n y of t h e s e symptoms a t t h e present time?

*

IF YES, PLEASE
NOTIFY THE
NURSE
QUESTIONNAIRE.
IF NO, CONTINUE THE QUESTIONNAIRE.

3.

What is your r a c i a l background?

4.

What is your s e x ?

5.

What is your a g e ?

6.

What is your m a r i t a l s t a t u s ?

7.

Do you live with

8.

What was your t o t a l family income last y e a r ?

AND

WHITE
MALE

NO

STOP

BLACK

THE

OTHER

FEMALE
—(Years)

Single

SPOUSE

5,000 - 10,000

20,000 - 30,000

Over 30,000

How long have you t a k e n insulin? —

Married

CHILDREN

Less t h a n $5,000

How long have you had d i a b e t e s ?
10.

NOW

YES

Widowed Divorced

FRIEND ALONE

10,000 - 20000

^Y
(Y e a r s >

OTHER
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11.

Did anyone t e a c h you how t o give yourself insulin a t t h a t time?
YES

NO

12.

Do you g i v e yourself t h e shot(s)?

13.

Who t a u g h t you how t o give your insulin?
SELF

14.

NURSE

NO

PHYSICIAN

OTHER

DO NOT KNOW

Who gives you t h e s h o t ?
SELF

15.

YES

FAMILY

FRIEND

OTHER

Please specify

When is t h e l a s t tim e you w e r e t a u g h t how t o give yourself
HAVE NEVER BEEN TAUGHT

LESS THAN ONE YEAR AGO

HAVE NOT RECEIVED ADDITIONAL TRAINING
16.

How many t i m e s a day d o you t a k e insulin?

17.

What kind of insulin d o you t a k e ?
NPH (Cloudy)

18.

Reg ( C l e a r )

insulin?

OTHER

BOTH

How many u n i t s d o you t a k e per day?

( t o t a l amount)

"As you may have h e a r d , t h e r e is some evidence t h a t diabetics may use their
disposable syringe a n d n e e d l e units for more than one injection.
19.

Do you t e n d t o a g r e e or d i s a g r e e with t h e following s t a t e m e n t ?
"It

is

O.K.

to

reuse

a

disposable

syringe

and

needle

for

insulin

injections."
STRONGLY DISAGREE
20.

AGREE

STRONGLY AGREE

Regardless of what you s a i d t o t h e l a s t question,
reused a s y r i n g e and needle t o inject your insulin.
YES

21.

DISAGREE

have

you

ever

NO

What is the most times you have reused a single syringe and needle unit
for s e l f - i n j e c t i o n ?
—
(if you h a v e never r eu s ed , p u t 0)
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In a month's
needles?

t i m e , how o f t e n h a v e you reused disposable svringe and

NEVER REUSED

LESS THAN ONCE A MONTH

ABOUT ONCE A MONTH

2 OR 3 TIMES A MONTH

ONCE A WEEK O R MORE
Do you use disposable s y r i n g e s a n d needles for more than one injection
currently?
YES

NO

Has anyone e v e r told you t h a t it was O . K. t o reuse your disposable
syringe and n e e d l e f o r more t h a n o n e injection?
YES

NO

Who told you t h a t it was O . K . t o r e u s e your syringe and needle unit?
NURSE

DOCTOR

NEVER BEEN TOLD

OTHER

Appendix B
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Vice President for Academic Affairs
P.O. Box W -1603
(601) 329-7142
Columbus, MS 39701

March 21, 1990

Ms. Anita J . S m a r t T u r n e r
Division of N u r s i n g
Campus
Dear Ms. T u r n e r :
The Committee o n U s e o f Human S u b j e c t s i n E x p e r i m e n t a t i o n h a s recommended
approval of y o u r p r o p o s a l . " E f f e c t s E x h i b i t e d b y E l d e r l y D i a b e t i c s Who R e u s e
Disposable I n s u l i n S y r i n g e s . " I am h a p p y t o a p p r o v e t h e i r r e c o m m e n d a t i o n .
Sincerely,

D o r o t h y Bu r d e s h a w
Interim Vice President
for Academic Affairs
DB: wr

cc:

Mrs. Mary P a t C u r t i s

Where Excellence is a Tradition
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Appendix C
February 19, 1990

To Whom It May Concern:
My name is Anita Turner. I am a registered nurse and graduate student
in nursing at Mississippi Univerisity for Women in Columbus,
Mississippi. I am conducting a research study related to the effects
exhibited by elderly diabetics who reuse insulin syringes.
As you know, people with diabetes suffer a long term chronic illness
with many costly medical expenses. Health care professionals are
looking for ways to assist individuals to maintain their health in the
most cost effective manner possible. Participation in the research can
provide data to support a change in current policy for the reuse of
insulin syringes and assist clients financially.
I am requesting your assistance in collecting data for study by
allowing me to administer a questionnaire to insulin dependent
diabetics who meet the criteria for this study. This should not require
more than one-half hour of their time to complete, and I will come at
their convenience.
I will use
Anonymity
__ —
questionnaires and all data will be analyzed a s a gro p.
On completion of my study, I will provide you with a summary of the
findings if you so desire.
Thank you for your cooperation.
Sincerely,

Anita Turner, R.N.,C., B.S.N.
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Appendix D

Agency's Memorandum of Agreement
Concerning Nursing Study

Expost facto Study:

A study of e f f e c t s exhibited by elderly diabetics
who reuse disposable insulin syringes

Name of the Institution or Agency:_
Study discussed with and explained to:

-

Name of Representative
Involvement in Study:
Cooperation: consent for subjects to be used in study

Communication Concerning Clients:
At intervals (specify)
As indicated
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Appendix E
Consent Form

Dear Participant:
My name is Anita T u r n e r . I a m a r e g i s t e r e d nurse and a g r a d u a t e
student at Mississippi University f o r Women. O n e of my major i n t e r e s t s
is improving t h e c a r e of d i a b e t i c s . I am i n t e r e s t e d in t h e e f f e c t s
exhibited by elderly d i a b e t i c s who r e u s e t h e i r insulin syringes.
Participation in t h e r e s e a r c h p r o j e c t would include answering a short
questionnaire
about
yourself
and
your
insulin
administration.
Participation in t h e s t u d y is v o l u n t a r y . All i n f o r m a t i o n g a t h e r e d during
the study will b e s t r i c t l y c o n f i d e n t i a l a n d no names will b e used on
any of the q u e s t i o n n a i r e s . You may withdraw a t a n y t i m e . Results ot
this study will help d e t e r m i n e t h e e f f e c t s of reusing insulin syringes.
Thank you for your tim e and c o o p e r a t i o n in t h i s s t u d y . If you h a v e any
questions, please c a l l me a t 7 2 8 - 7 9 6 8 .
Sincerely,

Anita Turner, R.N.,C., B.S.N.

I volunteer

to

have

a

free

blood

sugar

test

and

answer

questionnaire provided.
Name
Date

the

